Jeffrey Hanson

Title: The Innovative Contributions of Jeffrey Hanson

Introduction

Jeffrey Hanson is a notable inventor based in Oakland, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody production methods. With a total of 3 patents to his name, his work has the potential to impact therapeutic and diagnostic applications.

Latest Patents

Hanson's latest patents include innovative methods for producing full-length antibodies. One of his disclosures outlines a method that achieves a yield of at least about 200 mg/L. This method utilizes cells with an oxidative cytoplasm, which is crucial for maintaining the three-dimensional structure and stability of proteins that contain disulfide bonds. Additionally, he has developed anti-ROR1 antibody conjugates, which are designed for binding specificity to receptor tyrosine kinase orphan receptor 1 (ROR1) and its isoforms. These antibody conjugates have applications in therapeutic and diagnostic methods, showcasing the versatility of his inventions.

Career Highlights

Jeffrey Hanson is currently employed at Sutro Biopharma, Inc., where he continues to advance his research in antibody technology. His work at this company has positioned him as a key player in the biotechnology sector, contributing to the development of novel therapeutic solutions.

Collaborations

Hanson collaborates with talented individuals such as Amandeep Gakhal and Abigail Yu. Their combined expertise enhances the innovative environment at Sutro Biopharma, Inc., fostering the development of groundbreaking biopharmaceuticals.

Conclusion

Jeffrey Hanson's contributions to the field of biotechnology through his patents and collaborative efforts highlight his role as an influential inventor. His work in antibody production methods is paving the way for advancements in therapeutic and diagnostic applications.